What research gaps exist regarding the use of cannabinoids in pediatrics?
What research gaps exist regarding the use of cannabinoids in pediatrics? Research gaps regarding the use of cannabinoids in pediatrics include limited clinical studies, a lack of understanding of long-term effects, and insufficient data on optimal dosing and formulations for children. Most existing research has focused on adult populations, leaving a gap in knowledge about how cannabinoids affect developing brains and bodies in pediatric patients. Additionally, ethical considerations regarding research in children present challenges in conducting studies. Addressing these gaps requires increased funding for pediatric cannabinoid research, collaboration between healthcare providers and researchers, and the development of age-appropriate formulations to ensure safe and effective cannabinoid therapies for children (Ghosh et al., 2020).